JH013 Injection First-in-Human Safety Study
This trial is testing a new investigational drug called JH013 in healthy volunteers. It’s a first-in-human study to see how the drug is processed by the body and to check for safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- You are generally healthy with no major medical conditions.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female.
- Your body mass index (BMI) is between 18 and 26.
- You have no history of cancer, autoimmune disease, or organ transplant.
- You have not had a serious infection or received certain medications in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new monoclonal antibody (a type of protein medicine) called ISH0613 in healthy volunteers. The study will look at how safe the drug is, how your body handles it, and what effects it has.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
This trial tests a new drug called HS-20136-2 in healthy people to see how it works in the body and if it's safe. It's a Phase 1 study to gather early information before testing in patients.
Hear when a new Healthy Subjects (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.